VMAT2 and dopamine neuron loss in a primate model of Parkinson’s disease-Reference-Cited by-同舟云学术

VMAT2 and dopamine neuron loss in a primate model of Parkinson’s disease

Published:2008-04 Issue:1 Volume:105 Page:78-90
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J Neurochem

Author:

Chen Ming-Kai,Kuwabara Hiroto,Zhou Yun,Adams Robert J.,Brašić James R.,McGlothan Jennifer L.,Verina Tatyana,Burton Neal C.,Alexander Mohab,Kumar Anil,Wong Dean F.,Guilarte Tomás R.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2007.05108.x/fullpdf

Reference44 articles.

1. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

2. Positron Emission Tomography of Monoaminergic Vesicular Binding in Aging and Parkinson Disease

3. Imaging end points for monitoring neuroprotection in Parkinson's disease

4. Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration

5. Imaging the Peripheral Benzodiazepine Receptor Response in Central Nervous System Demyelination and Remyelination

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Cocaine Use and Parkinson’s Disease: An Interpretative Model;International Journal of Environmental Research and Public Health;2024-08-21

2. Experimental Parkinson models and green chemistry approach;Behavioural Brain Research;2024-08

3. Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology;NeuroToxicology;2024-07

4. Dopaminergic cell protection and alleviation of neuropsychiatric disease symptoms by VMAT2 expression through the class I HDAC inhibitor TC‐H 106;Pharmacology Research & Perspectives;2023-09-23

5. Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies;Cell;2023-08